Tyler Zeronda - Dec 31, 2024 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Mutya Harsch, Attorney-in-Fact
Stock symbol
VYNE
Transactions as of
Dec 31, 2024
Transactions value $
-$15,661
Form type
4
Date filed
1/2/2025, 05:45 PM
Previous filing
Oct 2, 2024
Next filing
Jan 23, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNE Common Stock Tax liability -$15.7K -4.68K -3.55% $3.35 127K Dec 31, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.